Video

Dr. Gomella Discusses Interdisiplinary Treatment

Author(s):

Leonard G. Gomella, MD

Leonard G. Gomella, MD from the Jefferson Kimmel Cancer Center Discusses Interdisiplinary Treatment

Related Videos
Timothy Hughes, MD, MBBS, FRACP, FRCPA
Anthony V. D'Amico, MD, PhD
Ana Christina Garrido-Castro, MD
Jennifer R. Eads, MD, physician lead, GI Cancer Research, director, National Clinical Trials Network, Abramson Cancer Center, University of Pennsylvania, associate professor, clinical medicine (hematology-oncology), Penn Medicine, Perelman Center for Advanced Medicine
Jean-Marc Classe, MD, PhD, Nantes Université
Bradley McGregor, MD
Kevin Kalinsky, MD, MS
Petros Grivas, MD, PhD; and Chandler Park, MD, MSc, FACP
Arndt Vogel, MD
Related Content
Sundar Jagannath, MBBS, director, the Center of Excellence for Multiple Myeloma, professor, Medicine, Mount Sinai Tisch Cancer Institute
June 7th 2024

Linvoseltamab Generates Efficacy Similar to That Seen With Teclistamab in R/R Myeloma

Neeraj Agarwal, MD
July 17th 2023

FDA Approval Insights: Talazoparib Plus Enzalutamide in HRR Gene–Mutated mCRPC

Fernando Cotait Maluf, MD
June 7th 2024

Pembrolizumab With Platinum-Based Therapy is Safe and Efficacious in PSCC

Andrew J. Armstrong, MD, MSc
June 15th 2023

FDA Approval Insights: Olaparib Plus Abiraterone in BRCA-Mutated mCRPC

Roger Li, MD
June 6th 2024

High CR Rate in NMIBC Is Maintained by Cretostimogene Grenadenorepvec Plus Pembrolizumab

Ronald C. Chen, MD, MPH, FASCO, FASTRO
June 6th 2024

Intensification With Apalutamide/ADT Improves PSA PFS in Biochemically Recurrent Prostate Cancer